We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies

News   Jul 12, 2016

 
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
 
 
 

RELATED ARTICLES

Why Do Our Immune Responses Differ?

News

A study of 1,000 individuals has identified three main factors that determine how our immune responses differ. The research might help identify ways to make better vaccines and improve our understanding of autoimmune disease.

READ MORE

Effective Approach to Optimizing Medicinal Molecules Developed

News

Lobachevsky University scientists develop an effective approach to optimizing medicinal molecules, which will significantly accelerate and automate the process of prototype optimization to candidate molecules for subsequent preclinical testing.

READ MORE

Antibody can Block B Cells from Fighting HIV

News

In certain people living with HIV, the antibody IgG3 stops the immune system’s B cells from doing their normal job of fighting pathogens, potentially the body's way to curb damaging immune hyperactivity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE